Rurioctocog alfa |
BLB-200; rAHF-PFM |
Approved |
Baxalta Incorporated |
百因止, Advate |
United States |
Hemophilia A |
null |
2003-07-25 |
Hemophilia A |
Details
|
Enoxaparin Sodium |
PRY-005; PK-10169; XRP-4563K; M-enoxaparin; RP-54563; RPY-005 |
Approved |
Sanofi |
Klexane, 克赛, Lovenox, Clexane, Enoxamed |
United States |
Pulmonary Embolism; Venous Thrombosis |
Sanofi-Aventis U.S. Llc |
1993-03-29 |
Lung Neoplasms; Respiratory Distress Syndrome, Adult; Liver Diseases; Thromboembolism; Pre-Eclampsia; Coronary Disease; Coronavirus Infections; Fetal Growth Retardation; Cardiovascular Diseases; Venous Thrombosis; Hypoxia; Obstetric Labor, Premature; Nephrotic Syndrome; Thrombophilia; Intraoperative Complications; Postoperative Complications; Thrombosis; Carcinoma, Non-Small-Cell Lung; Catheter-Related Infections; Non-ST Elevated Myocardial Infarction; Brain Injuries, Traumatic; Ovarian Neoplasms; Myocardial Ischemia; Venous Thromboembolism; ST Elevation Myocardial Infarction; Myocardial Infarction; Esophageal Neoplasms; Stomach Neoplasms; Abdominal Neoplasms; Angina, Unstable; Pulmonary Embolism; Kidney Diseases; Colonic Neoplasms; Neoplasms; Coronavirus Disease 2019 (COVID-19); Obesity, Morbid; Pancreatic Neoplasms; Hip Fractures; Virus Diseases; Acute Coronary Syndrome |
Details
|
Enoxaparin sodium biosimilar (Gland Pharma) |
|
Approved |
Gland Pharma Ltd |
Cutenox |
|
Angina, Unstable; Myocardial Infarction; Venous Thromboembolism; Venous Thrombosis |
Gland Pharma |
2014-10-01 |
Angina, Unstable; Myocardial Infarction; Venous Thromboembolism; Venous Thrombosis |
Details
|
Human coagulation factor Ⅷ (Chengdu Rongsheng Pharmaceuticals) |
|
Approved |
Chengdu Rongsheng Pharmaceuticals Co Ltd |
|
Mainland China |
Hemophilia A |
Chengdu Rongsheng Pharmaceuticals Co Ltd |
2001-01-01 |
Hemophilia A |
Details
|
Von Willebrand factor/coagulation factor VIII complex (human, Octapharma) |
|
Approved |
Octapharma |
Wilate, Eqwilate, Wilnativ |
Germany |
Hemophilia A; von Willebrand Diseases |
Octapharma |
2005-01-01 |
von Willebrand Diseases; Hemophilia A |
Details
|
Human coagulation factor VIII (China Biologic Products) |
|
Approved |
Taibang Biotech (Shandong) Co Ltd |
|
Mainland China |
Hemophilia A |
Taibang Biotech (Shandong) Co Ltd |
2012-06-15 |
Hemophilia A; Hemorrhage; Blood Loss, Surgical |
Details
|
Enoxaparin sodium biosimilar (Apotex Pty Ltd) |
|
Approved |
Apotex |
|
Australia |
Myocardial Ischemia; Angina, Unstable; Venous Thromboembolism; Thrombosis; Venous Thrombosis |
Apotex |
2020-02-10 |
Myocardial Ischemia; Angina, Unstable; Venous Thromboembolism; Venous Thrombosis; Thrombosis |
Details
|
Anti-inhibitor coagulant complex (Baxalta) |
|
Approved |
Baxalta Incorporated |
PROPLEX 600, Prothromplex, Prothromplex 600, Prothromplex 600 IE, Prothromplex 600 SV, Prothromplex 600 TV, Prothromplex 600 UI, Prothromplex NF 600, PROPLEX, Feiba, Prothromplex TOTAL |
United States |
Hemophilia B; Hemophilia A |
Baxalta Incorporated |
1979-12-21 |
Blood Coagulation Disorders; Blood Coagulation Disorders, Inherited; Hemophilia A; Hemophilia B; Cardiovascular Diseases |
Details
|
Apixaban |
BMS-562247-01; BMS-562247; TAH-3311 |
Approved |
Bristol-Myers Squibb Company |
Eliquis, 艾乐妥, 艾乐通 |
EU |
Venous Thromboembolism |
Bristol-Myers Squibb/Pfizer Eeig |
2011-05-18 |
Thrombocytopenia; Atrial Fibrillation; Ischemic Attack, Transient; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Aortic Valve Insufficiency; Astrocytoma; Primary Myelofibrosis; Colitis, Ulcerative; Ischemic Stroke; Colonic Diseases; Genital Neoplasms, Female; Lymphoma; Glomerulonephritis, Membranous; Venous Thrombosis; Aortic Valve Stenosis; Nephrotic Syndrome; Thrombosis; Kidney Failure, Chronic; Thrombocythemia, Essential; Rectal Diseases; Crohn Disease; Fasting; Anemia, Sickle Cell; Pancreatic Neoplasms; Pulmonary Embolism; Embolism; Hematologic Neoplasms; Solid tumours; Venous Thromboembolism; Cerebral Hemorrhage; Spinal Cord Injuries; Inflammatory Bowel Diseases; Polycythemia Vera; Foramen Ovale, Patent; Atrial Flutter; Bone Marrow Neoplasms; Aortic valve diseases; Myeloproliferative Disorders; Glioblastoma; Neoplasms; Coronavirus Disease 2019 (COVID-19); Proteinuria; Acute Coronary Syndrome; Stroke; Thromboembolism; Hemorrhage |
Details
|
Turoctocog alfa |
NNC0155-0000-0004; NN-7008 |
Approved |
Novo Nordisk A/S |
Zonovate, Novoeight |
United States |
Hemophilia A |
null |
2013-10-15 |
Hemophilia A; Hemorrhage |
Details
|
Human prothrombin complex (Nanyue Biopharming) |
|
Approved |
Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd |
|
Mainland China |
Hemorrhage |
Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd |
2019-09-05 |
Hemophilia B; Hemorrhage |
Details
|
Human Antithrombin III (Hemarus Therapeutics) |
|
Approved |
Hemarus Therapeutics |
|
India |
Antithrombin III Deficiency |
Hemarus Therapeutics |
2015-08-01 |
Antithrombin III Deficiency |
Details
|
Enoxaparin sodium biosimilar (Techdow) |
|
Approved |
Shenzhen Techdow Pharmaceutical Co Ltd |
Inhixa |
Mainland China |
Embolism and Thrombosis |
Shenzhen Techdow Pharmaceutical Co Ltd |
2005-08-18 |
Pulmonary Embolism; Blood Coagulation Disorders; Venous Thromboembolism; Angina, Unstable; Coronavirus Disease 2019 (COVID-19); Embolism and Thrombosis; Coronavirus Infections; Pneumonia, Viral; Venous Thrombosis; Non-ST Elevated Myocardial Infarction |
Details
|
Moroctocog alfa |
PF-05208756; r-VIII SQ; PF-5208756; r-Factor VIII SQ; BDDrFVIII |
Approved |
Pfizer Inc |
ReFacto, Xyntha, Refacto AF, Xyntha Solofuse, Refacto AF/Xyntha, 任捷 |
EU |
Hemophilia A |
Pfizer Europe Ma Eeig |
1999-04-13 |
Hemophilia A |
Details
|
Heparin sodium biosimilar (Chandra Bhagat Pharma) |
|
Approved |
Chandra Bhagat Pharma(Cbc) |
Thromboparin |
India |
Thrombosis |
Chandra Bhagat Pharma(Cbc) |
2012-08-01 |
Thrombosis |
Details
|
Factor VIII (Tonrol Biopharmaceuticals) |
Hemorass |
Approved |
Tonrol Bio-Pharmaceutical Co Ltd |
HEMORAAS |
|
|
|
|
Hemophilia A |
Details
|
Danaparoid sodium |
KB-101; Org-10172 |
Approved |
Merck Sharp & Dohme Corp, Organon |
Orgaran, Lomoparan |
Netherlands |
Thrombocytopenia; Venous Thromboembolism |
null |
1991-01-01 |
Venous Thromboembolism; Thrombocytopenia; Venous Thrombosis |
Details
|
Eptacog alfa (Novo Nordisk) |
NN-007 |
Approved |
Novo Nordisk A/S |
NiaStase, NovoSeven, 诺其 |
EU |
Thrombasthenia; Factor VII Deficiency; Hemophilia A; Hemophilia B |
Novo Nordisk A/S |
1996-02-23 |
Cerebral Hemorrhage; Spinal Diseases; Hemophilia A; Hemophilia B; Liver Cirrhosis; Hemorrhage; Stroke; Postpartum Hemorrhage; Factor VII Deficiency; Severe Dengue; Burns; Blood Loss, Surgical; Wounds and Injuries; Thrombasthenia; Acquired hemophilia |
Details
|
Human prothrombin complex (CSL Behring) |
BE-1116 |
Approved |
Csl Behring Llc |
Kcentra, Beriplex, Confidex |
Japan |
Vitamin K Deficiency Bleeding |
Csl Behring Kk |
|
Coagulation Protein Disorders; Blood Coagulation Disorders; Vitamin K Deficiency Bleeding; Heart Failure; Heart Diseases; Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Wounds and Injuries |
Details
|
Freeze-dried activated human blood coagulation factor Ⅶ concentrate containing factor Ⅹ (Kaketsuken/KM Biologics) |
MC-710 |
Approved |
KM Biologics Co Ltd |
Byclot |
Japan |
Hemophilia A |
null |
2014-07-04 |
Hemophilia A |
Details
|
Trenonacog alfa |
IB-1001; APVO-101 |
Approved |
Inspiration Biopharmaceuticals |
Ixinity |
United States |
Hemophilia B |
null |
2015-05-14 |
Hemophilia B |
Details
|
Human prothrombin complex concentrate (Guizhou Taibang Biological Products) |
|
Approved |
Guizhou Taibang Biological Products Co Ltd |
|
Mainland China |
Hypoprothrombinemias |
Guizhou Taibang Biological Products Co Ltd |
2013-07-31 |
Hypoprothrombinemias |
Details
|
Factor VIII (CSL) |
|
Approved |
Csl Ltd |
Beriate |
Sweden |
Hemophilia A |
Csl Behring Gmbh |
1997-06-06 |
Hemophilia A |
Details
|
Enoxaparin sodium biosimilar (PT Kalbe) |
|
Approved |
Kalbe Farma |
Kalbenox |
Cambodia |
Myocardial Infarction; Venous Thrombosis; Angina, Unstable |
Kalbe Farma |
2012-01-01 |
Myocardial Infarction; Angina, Unstable; Venous Thrombosis |
Details
|
Rivaroxaban |
JNJ-39039039; BAY-59-7939; YHP-1807; YHR-1901 |
Approved |
Bayer AG, Johnson & Johnson Pharmaceutical Research & Development LLC |
Xarelto, 拜瑞妥 |
Canada |
Atherosclerosis |
Bayer AG |
2008-09-15 |
Intraoperative Complications; Antiphospholipid Syndrome; Coronary Disease; Atrial Fibrillation; Osteoarthritis, Knee; Rheumatic Heart Disease; Rheumatic Diseases; Cardiovascular Diseases; Urologic Neoplasms; Venous Thrombosis; Thrombocytopenia; Arthritis; Hemorrhage; Renal Insufficiency, Chronic; Postoperative Complications; Obesity; Thrombosis; Heart Defects, Congenital; Peripheral Arterial Disease; Osteoarthritis, Hip; Respiratory Insufficiency; Kidney Failure, Chronic; Anemia, Sickle Cell; Communicable Diseases; Myocardial Ischemia; Embolism; Upper Extremity Deep Vein Thrombosis; Heart Failure; Angina, Unstable; Venous Thromboembolism; Myocardial Infarction; Mitral Valve Stenosis; Atherosclerosis; Diabetes Mellitus, Type 2; Pulmonary Embolism; Arterial Occlusive Diseases; Coronary Artery Disease; Coronavirus Disease 2019 (COVID-19); Neoplasms; Obesity, Morbid; beta-Thalassemia; Thromboembolism; Stroke; Acute Coronary Syndrome; Embolism and Thrombosis |
Details
|
Human Coagulation Factor Ⅷ (Hualan Biological Engineering) |
|
Approved |
Hualan Genetic Engineering Co Ltd |
康斯平, Kangsiping |
Mainland China |
Blood Coagulation Disorders; Hemophilia A |
Hualan Biological Engineering Inc |
2000-01-01 |
Blood Coagulation Disorders; Hemophilia A |
Details
|
Antithrombin III (Human, Grifols) |
|
Approved |
Grifols Sa |
Thrombate III |
United States |
Thromboembolism; Antithrombin III Deficiency |
null |
1991-12-30 |
Venous Thromboembolism; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis; Heart Diseases; Thromboembolism; Antithrombin III Deficiency; Wounds and Injuries; Postoperative Complications; Venous Thrombosis |
Details
|
Susoctocog alfa |
BAX-801; OBI-1; TAK-672; SHP-672; BAX-802 |
Approved |
Baxalta Incorporated |
Obizur |
United States |
Hemophilia A |
null |
2014-10-23 |
Hemophilia A; Hemorrhage; Acquired hemophilia |
Details
|
Enoxaparin sodium biosimilar (Neiss Labs) |
|
Approved |
Neiss Labs |
Lomonox |
India |
Venous Thrombosis |
Neiss Labs |
2012-08-01 |
Venous Thrombosis |
Details
|
Certoparin sodium |
|
Approved |
Novartis Pharma Ag |
Troparin, Alphaparin, Sandoparin, Sandoparine, Mono-Embolex |
|
Pulmonary Embolism; Thromboembolism; Venous Thrombosis |
null |
1997-01-01 |
Embolism; Pulmonary Embolism; Renal Insufficiency; Kidney Diseases; Thromboembolism; Atrial Fibrillation; Venous Thrombosis |
Details
|
Parnaparin sodium |
OP-2123; CB-01-05 |
Approved |
Opocrin Spa, Alfasigma Spa |
Fluxum, Lowhepa, Minidalton |
Italy |
Thrombosis |
null |
1993-01-01 |
Thrombophlebitis; Infertility; Thrombosis |
Details
|
Octocog alfa |
BAY14-2222 |
Approved |
Bayer AG |
Kogenate, Helixate NexGen, Kovaltry, Iblias, Kogenate/Kovaltry, 科跃奇 |
United States |
Hemophilia A |
Bayer Healthcare |
1993-02-25 |
Blood Coagulation Disorders; Hemophilia A |
Details
|
Moroctocog alfa biosimilar (International Biotech Center Generium) |
GNR-002 |
Approved |
International Biotech Center Generium |
Octofactor |
Russian Federation |
Hemophilia A |
International Biotech Center Generium |
2013-01-01 |
Hemophilia A |
Details
|
Antihemophilic factor/von Willebrand factor (CSL Behring) |
|
Approved |
Csl Behring Llc |
Aleviate, Voncento, Humate-P, Biostate, Haemate P |
United States |
von Willebrand Diseases; Hemophilia A |
null |
1999-04-01 |
von Willebrand Diseases; Hemophilia A |
Details
|
Antihemophilic factor B (Armour) |
|
Approved |
Csl Behring Llc, Armour Pharma |
MonoFIX, Mononine |
|
Hemophilia B |
null |
1993-05-01 |
Hemophilia B |
Details
|
Ardeparin sodium |
|
Approved |
Wyeth-Ayerst |
Normiflo |
United States |
Pulmonary Embolism; Venous Thrombosis |
null |
1997-05-01 |
Pulmonary Embolism; Venous Thrombosis |
Details
|
Dalteparin Sodium |
FR-860; KV-165; KABI-2165 |
Approved |
Pfizer Inc |
法安明, Fragmin |
Germany |
Thrombosis |
Pfizer Inc |
1985-01-01 |
Puerperal Disorders; Thrombosis; Anemia, Sickle Cell; Thrombophilia; Venous Thrombosis; Lung Neoplasms; Pregnancy Complications; Colorectal Neoplasms; Parturition; Brain Neoplasms; Atrial Fibrillation; Hepatic Veno-Occlusive Disease; Prostatic Neoplasms; Breast Neoplasms; Diabetic Foot; Abortion, Habitual; Thromboembolism; Central Nervous System Neoplasms; Stroke; Coronary Artery Disease; Neoplasms; Renal Insufficiency; Angina, Unstable; Myocardial Infarction; Brain Injuries, Traumatic; Venous Thromboembolism; Ovarian Neoplasms; Pulmonary Embolism |
Details
|
Turoctocog alfa pegol |
NN-7088; N8-GP; N8-GP-rFVIII; NNC-0129-0000-1003 |
Approved |
Novo Nordisk A/S |
Esperoct |
United States |
Hemophilia A |
Novo Nordisk Inc |
2019-02-19 |
Hemophilia A; Hemorrhage |
Details
|
NecLip-pdFVIII |
pdFVIII |
Approved |
Recoly Nv |
LongAte, LongEight |
|
|
|
|
Hemophilia A |
Details
|
Prothrombinex-VF (CSL Behring) |
|
Approved |
Csl Behring Llc |
|
Australia |
Hemorrhage |
Csl Behring Llc |
2014-10-01 |
Hemorrhage |
Details
|
Factor VIII (Shanxi Kangbao Biological Products) |
|
Approved |
Shanxi Kangbao Biological Product Co Ltd |
|
Mainland China |
Hemophilia A |
Shanxi Kangbao Biological Product Co Ltd |
2020-08-14 |
Hemophilia A |
Details
|
Factor VIII biosimilar (Chia Tai-Tianqing) |
KN-008 |
Approved |
Suzhou Alphamab Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
安恒吉 |
Mainland China |
Hemophilia A |
Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group |
2023-08-29 |
Hemophilia A |
Details
|
Recombinant Human Coagulation Factor VIII (sinocelltech) |
SCT-800 |
Approved |
SinoCelltech Ltd |
|
Mainland China |
Hemophilia A |
SinoCelltech Ltd |
2021-07-20 |
Hemophilia A; Blood Loss, Surgical |
Details
|
Efmoroctocog alfa |
BIIB-031; rFVIIIFc |
Approved |
Biogen Inc, Sobi, Bioverativ Inc |
Elocta, Eloctate |
United States |
Hemophilia A |
null |
2014-06-06 |
Hemophilia A |
Details
|
Efanesoctocog alfa |
BIVV-001; BIVV001 |
Approved |
Amunix Pharmaceuticals Inc |
Altuviiio |
United States |
Hemophilia A |
Sanofi |
2023-02-23 |
von Willebrand Diseases; Hemophilia A |
Details
|
Lonoctocog alfa |
CSL-627; NBP-601 |
Approved |
Sk Chemicals, Csl Behring Llc |
Afstyla |
United States |
Hemophilia A |
Csl Behring Ag |
2016-05-25 |
Hemophilia A |
Details
|
Antihemophilic Factor (Recombinant) |
|
Approved |
Baxalta Incorporated |
Recombinate |
United States |
Hemophilia A |
null |
1992-12-10 |
Hemophilia A |
Details
|
Prothrombin complex concentrate (Sanquin) |
|
Approved |
Sanquin Plasma Products Bv |
Cofact |
|
Hemorrhage |
Sanquin Plasma Products Bv |
2007-11-01 |
Hemorrhage |
Details
|
Enoxaparin sodium biosimilar (Rovi) |
|
Approved |
Rovi |
Arovi |
|
Angina, Unstable; Myocardial Infarction; Venous Thrombosis |
Rovi |
2018-03-31 |
Angina, Unstable; Myocardial Infarction; Venous Thrombosis |
Details
|
Emicizumab |
RG-6013; ACE-910; RO-5534262 |
Approved |
Genentech Inc, Chugai Pharmaceutical Co Ltd |
舒友立乐, Hemlibra |
United States |
Hemophilia A |
Genentech Inc |
2017-11-16 |
Hemophilia A; Hemorrhage; von Willebrand Disease, Type 3 |
Details
|
Human Coagulation Factor IX (Hemarus Therapeutics) |
|
Approved |
Hemarus Therapeutics |
Clotnine |
India |
Hemophilia B |
Hemarus Therapeutics |
2015-08-01 |
Hemophilia B |
Details
|
Human Coagulation Factors IX and X (CSL Behring) |
|
Approved |
Csl Behring Llc |
Factor X P Behring |
|
|
|
|
Hemophilia B |
Details
|
Enoxaparin sodium biosimilar (Blau Pharmaceuticals) |
|
Approved |
Blau Pharmaceuticals |
Enoxalow |
|
Thrombosis |
Blau Pharmaceuticals |
2013-07-01 |
Thrombosis |
Details
|
Nonacog alfa |
rh-F-IX; rh-Factor-IX |
Approved |
Pfizer Inc |
贝赋, BeneFIX |
EU |
Hemophilia B |
Pfizer Europe Ma Eeig |
1997-08-27 |
Hemophilia B |
Details
|
Eptacog alfa biosimilar (AryoGen Biopharma) |
|
Approved |
Aryogen Biopharma |
|
Iran |
Factor VII Deficiency; Hemophilia A; Hemophilia B; Thrombasthenia |
Aryogen Biopharma |
2014-01-01 |
Hemophilia A; Hemophilia B; Factor VII Deficiency; Thrombasthenia |
Details
|
Nonacog alfa (International Biotech Center Generium) |
GNR-003 |
Approved |
International Biotech Center Generium |
Innonafactor |
Russian Federation |
Hemophilia B |
International Biotech Center Generium |
2014-01-01 |
Hemophilia B |
Details
|
Factor IX complex (Grifols) |
|
Approved |
Grifols Sa |
Profilnine |
United States |
Hemophilia B |
null |
1981-07-21 |
Intracranial Hemorrhages; Hemophilia B |
Details
|
Edoxaban Tosilate Hydrate |
DU-176b |
Approved |
Daiichi Sankyo Co Ltd |
Savaysa, 里先安, Roteas, Lixiana, Lixiana/Savaysa |
Japan |
Pulmonary Embolism; Embolism; Stroke; Venous Thromboembolism; Venous Thrombosis |
Daiichi Sankyo Co Ltd |
2011-04-22 |
Embolism and Thrombosis; Thrombosis; Obesity; Inflammation; Aortic Valve Stenosis; Venous Thrombosis; Osteoarthritis, Knee; Ischemic Stroke; Atrial Fibrillation; Pulmonary Embolism; Stroke; Thromboembolism; Neoplasms; Heart Diseases; Venous Thromboembolism; HIV Infections; Embolism |
Details
|
Nonacog beta pegol |
N9-GP; NN-7999; 40K-PEG-rFIX; NNC-0156-0000-0009 |
Approved |
Novo Nordisk A/S |
Rebinyn, Refixia |
United States |
Hemophilia B |
Novo Nordisk Inc |
2017-05-31 |
Hemophilia B; Hemorrhage |
Details
|
Human coagulation factor VIII (Green Cross Biological Products) |
|
Approved |
GC Biopharma Corp |
|
Mainland China |
Blood Coagulation Disorders |
Green Cross China Biological Products Co Ltd |
2000-01-01 |
Blood Coagulation Disorders |
Details
|
Enoxaparin sodium biosimilar (Harvest Moon Pharmaceuticals) |
|
Approved |
Harvest Moon |
|
|
|
|
|
Angina, Unstable; Myocardial Infarction; Venous Thromboembolism; Venous Thrombosis |
Details
|
Eptacog beta |
LR-769; rhFVIIa |
Approved |
Lfb Biotechnologies Sas, Revo Biologics Inc |
Sevenfact |
United States |
Hemophilia A; Hemophilia B |
Lfb Biotechnologies Sas |
2020-04-01 |
Hemophilia A; Hemophilia B |
Details
|
Simoctocog alfa |
Factor VIII; Human-cl rhFVIII |
Approved |
Octapharma |
Vihuma, Nuwiq |
EU |
Hemophilia A |
Octapharma Ab |
2014-07-22 |
Hemophilia A |
Details
|
Human prothrombin complex (Octapharma) |
|
Approved |
Octapharma |
Ocplex, Octaplex, Pronativ |
Germany |
Hemorrhage |
Octapharma |
2003-03-14 |
Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
Nonacog gamma |
rFIX; BAX-326 |
Approved |
Baxalta Incorporated |
Rixubis |
United States |
Hemophilia B |
null |
2013-06-26 |
Hemophilia B |
Details
|
Factor VIII/von Willebrand factor (Bio Products Laboratory) |
|
Approved |
Bio Products Laboratory Ltd |
Optivate |
|
Hemophilia A |
Bio Products Laboratory Ltd |
2004-12-01 |
von Willebrand Diseases; Hemophilia A |
Details
|
Eptacog alfa biosimilar (International Biotech Center Generium) |
GNR-001 |
Approved |
International Biotech Center Generium |
|
Russian Federation |
Hemophilia A |
International Biotech Center Generium |
2015-01-01 |
Hemophilia A |
Details
|
Antihemophilic factor/von Willebrand factor complex (Human, Grifols Biologicals) |
|
Approved |
Grifols Sa |
Alphanate |
United States |
Hemophilia A; von Willebrand Diseases |
null |
1978-08-15 |
von Willebrand Diseases; Hemophilia A |
Details
|
Rurioctocog alfa pegol |
BAX-0855; BAX-855; TAK-660 |
Approved |
Baxalta Incorporated, Nektar Therapeutics |
Adynovi, Adynovate |
United States |
Hemophilia A |
null |
2015-11-13 |
Hemophilia A |
Details
|
Human prothrombin complex (LFB) |
|
Approved |
Lfb Biotechnologies Sas |
KANOKAD |
France |
Hemorrhage |
Lfb Biotechnologies Sas |
2008-09-01 |
Hemorrhage |
Details
|
Eftrenonacog Alfa |
BIIB-029; FIX:Fc; FIXFc; rFIXFc |
Approved |
Sobi, Biogen Inc, Bioverativ Inc |
Alprolix, 赛玖凝 |
United States |
Hemophilia B |
null |
2014-03-28 |
Hemophilia B |
Details
|
Factor VIII (Intas Pharmaceuticals) |
|
Approved |
Intas Biopharmaceuticals |
Factocel VIII |
|
|
|
|
Hemophilia A |
Details
|
Moroctocog alfa biosimilar (Amega Biotech) |
|
Approved |
Amega Biotech |
|
Argentina |
Hemophilia A |
Amega Biotech |
2012-01-01 |
Hemophilia A |
Details
|
Fondaparinux Sodium |
GSK-576428; Org-31540; SR-90107; SR-90107A |
Approved |
Organon |
Arixtra, Quixidar, 安卓 |
United States |
Venous Thrombosis; Liver Diseases; Pulmonary Embolism |
Mylan Ireland Ltd |
2001-12-07 |
Angina Pectoris; Uterine Cervical Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Venous Thrombosis; Sarcoma; Vulvar Neoplasms; Atrial Fibrillation; Coronary Disease; Liver Diseases; Pulmonary Embolism; Thromboembolism; Obesity, Morbid; Neoplasms; Vaginal Neoplasms; Renal Insufficiency; Venous Thromboembolism; Angina, Unstable; Myocardial Infarction; Ovarian Neoplasms |
Details
|
Enoxaparin sodium biosimilar (Chandra Bhagat Pharma) |
|
Approved |
Chandra Bhagat Pharma(Cbc) |
MAXIPARINE |
|
|
|
|
Venous Thrombosis |
Details
|
Antithrombin III (CSL Behring) |
BI51.017 |
Approved |
Csl Behring Llc |
Kybernin, Anthrobin, Athimbin |
Japan |
Thrombosis; Disseminated Intravascular Coagulation |
Csl Behring Llc |
1987-08-02 |
Disseminated Intravascular Coagulation; Thrombosis |
Details
|
Heparin sodium biosimilar (Blau Pharmaceuticals) |
|
Approved |
Blau Pharmaceuticals |
Hepamax-S |
Brazil |
Thrombosis |
Blau Pharmaceuticals |
2012-08-01 |
Thrombosis |
Details
|
Human prothrombin complex (Tonrol Biopharmaceuticals) |
|
Approved |
Tonrol Bio-Pharmaceutical Co Ltd |
ProthoRAAS |
Mainland China |
Hemorrhage |
Shanghai Raas Blood Products Co Ltd |
1996-01-01 |
Hemophilia B; Hemorrhage |
Details
|
Human Coagulation Factor VIII (Hemarus Therapeutics) |
|
Approved |
Hemarus Therapeutics |
CLOTATE |
India |
Hemophilia A |
Hemarus Therapeutics |
2015-08-01 |
Hemophilia A |
Details
|
Human factor IX (LFB) |
|
Approved |
Lfb Biotechnologies Sas |
Betafact |
Netherlands |
Hemophilia B |
Lfb Biotechnologies Sas |
2000-05-01 |
Hemophilia B |
Details
|
Albutrepenonacog alfa |
CSL-640; CSL-654 |
Approved |
Csl Behring Llc |
Idelvion |
United States |
Hemophilia B |
null |
2016-03-04 |
Hemophilia B |
Details
|
Enoxaparin sodium biosimilar (Fresenius Kabi) |
|
Approved |
Fresenius Kabi Canada Ltd |
ELONOX, ELONOX HP |
Canada |
Thromboembolism; Venous Thrombosis |
Fresenius Kabi Canada Ltd |
2022-10-26 |
Thromboembolism; Venous Thrombosis |
Details
|
Recombinant Human Coagulation Factor Ⅷ (Chengdu Rongsheng Pharmaceuticals) |
|
Approved |
Chengdu Rongsheng Pharmaceuticals Co Ltd |
|
Mainland China |
Hemophilia A |
Chengdu Rongsheng Pharmaceuticals Co Ltd |
2023-09-05 |
Hemophilia A |
Details
|
Human prothrombin complex (ShenzhenWeiguang Biological Products) |
|
Approved |
Shenzhen Weiguang Biological Products Co Ltd |
|
Mainland China |
Hemorrhage |
Shenzhen Weiguang Biological Products Co Ltd |
2024-05-21 |
Hemophilia B; Hemorrhage |
Details
|
Human prothrombin complex (Guangdong Shuanglin) |
|
Approved |
Guangdong Shuanglin Bio-Pharmaceutical Co Ltd |
|
Mainland China |
Hemophilia B |
Guangdong Shuanglin Bio-Pharmaceutical Co Ltd |
2023-05-12 |
Hemophilia B |
Details
|
Human coagulation factor Ⅷ (Shanghai Xinxing) |
|
Approved |
Shanghai Xinxing Medicine Co Ltd |
|
Mainland China |
Hemophilia A; Hemorrhagic Disorders |
Shanghai Xinxing Medicine Co Ltd |
2015-07-27 |
Hemorrhagic Disorders; Hemophilia A |
Details
|
Human coagulation factor Ⅷ (Shanghai Institute of Biological Products) |
|
Approved |
Shanghai Institute Of Biological Products Co Ltd |
|
Mainland China |
Hemorrhagic Disorders; Hemophilia A |
Shanghai Institute Of Biological Products Co Ltd |
2012-07-23 |
Hemorrhagic Disorders; Hemophilia A |
Details
|
Human coagulation factor Ⅷ (Shandong Taibang) |
|
Approved |
Shandong Taibang Biological Products Co Ltd |
|
Mainland China |
|
Shandong Taibang Biological Products Co Ltd |
2012-06-15 |
|
Details
|
Human Coagulation Factor Ⅷ (Sinopharm Shanghai Plasma) |
|
Approved |
Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd |
|
Mainland China |
Hemophilia A |
Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd |
2012-07-23 |
Hemophilia A |
Details
|
Human prothrombin complex (Shanghai Xinxing) |
|
Approved |
Shanghai Xinxing Medicine Co Ltd |
|
Mainland China |
Hemorrhage |
Shanghai Xinxing Medicine Co Ltd |
1997-01-01 |
Hemorrhage |
Details
|
Human prothrombin complex (Sinopharm Shanghai Plasma) |
|
Approved |
Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd |
|
Mainland China |
Hemorrhage |
Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd |
1997-01-01 |
Hemorrhage |
Details
|
Human prothrombin complex (Boya Bio-Pharmaceutical) |
|
Approved |
Boya Bio-Pharmaceutical Group Co Ltd |
|
Mainland China |
Hemorrhage |
Boya Bio-Pharmaceutical Group Co Ltd |
2020-12-02 |
Hemophilia B; Hemorrhage |
Details
|
Human prothrombin complex (Guangdong Wellen) |
|
Approved |
Guangdong Wellen Pharmaceutical Co Ltd |
|
Mainland China |
Hemorrhage |
Guangdong Wellen Pharmaceutical Co Ltd |
2020-10-21 |
Hemophilia B; Hemorrhage |
Details
|
Human Coagulation Factor Ⅷ (Shanghai Raas Blood Products) |
|
Approved |
Shanghai Raas Blood Products Co Ltd |
|
Mainland China |
Hemophilia A |
Shanghai Raas Blood Products Co Ltd |
1995-01-01 |
Hemophilia A |
Details
|
Factor IX (Bio Products Laboratory) |
|
Approved |
Bio Products Laboratory Ltd |
Replenine-VF |
United Kingdom |
Hemophilia B |
Bio Products Laboratory Ltd |
1999-08-09 |
Hemophilia B |
Details
|
Human prothrombin complex (Lanzhou Lansheng Blood Products) |
|
Approved |
Lanzhou Lansheng Blood Products Co Ltd |
|
Mainland China |
Hemophilia B |
Lanzhou Lansheng Blood Products Co Ltd |
2024-09-26 |
Hemophilia B |
Details
|
Human Coagulation Factor Ⅷ(Tonrol Bio-Pharmaceutical ) |
|
Approved |
Tonrol Bio-Pharmaceutical Co Ltd |
|
Mainland China |
Hemophilia A |
Tonrol Bio-Pharmaceutical Co Ltd |
2013-08-23 |
Hemophilia A |
Details
|
Antithrombin III (Octapharma Ab) |
|
Approved |
Octapharma Ab |
Atenativ |
EU |
Antithrombin III Deficiency |
Octapharma Ab |
2007-12-20 |
Antithrombin III Deficiency |
Details
|
Human prothrombin complex(Hebei Daan Pharmaceutical) |
|
Approved |
Hebei Daan Pharmaceutical Co Ltd |
|
Mainland China |
Hemorrhage |
Hebei Daan Pharmaceutical Co Ltd |
2020-01-01 |
Hemophilia B; Hemorrhage |
Details
|
Human Coagulation Factor Ⅷ (Jiangxi Boya Bio-Pharmaceutical ) |
|
Approved |
Boya Bio-Pharmaceutical Group Co Ltd |
|
Mainland China |
Hemophilia A |
Boya Bio-Pharmaceutical Group Co Ltd |
2022-08-08 |
Hemophilia A; Hemorrhage |
Details
|
Human Coagulation Factor Ⅷ (Guangdong Shuanglin Bio-Pharmaceutical) |
|
Approved |
Guangdong Shuanglin Bio-Pharmaceutical Co Ltd |
|
Mainland China |
Hemophilia A |
Guangdong Shuanglin Bio-Pharmaceutical Co Ltd |
2020-06-17 |
Hemophilia A |
Details
|
Human coagulation factor Ⅷ (Shenzhen Weiguang Biological Products) |
|
Approved |
Shenzhen Weiguang Biological Products Co Ltd |
|
Mainland China |
Hemophilia A |
Shenzhen Weiguang Biological Products Co Ltd |
2023-10-27 |
Hemophilia A |
Details
|
Polysulfonic mucopolysaccharide |
M-118102; M-1180B; M-7040B |
Approved |
Maruho Co Ltd |
喜辽妥, 喜疗妥 |
Japan |
Thrombophlebitis; Arthritis; Cicatrix; Chilblains |
Maruho Co Ltd |
1954-10-01 |
Phlebitis; Thrombophlebitis; Cicatrix; Chilblains; Contusions; Arthritis |
Details
|
Human coagulation factor VIII(Biotest Pharma Gmbh) |
|
Approved |
Biotest Pharma Gmbh |
Haemoctin SDH |
|
|
|
|
Hemophilia A |
Details
|
Human Coagulation Factor IX(China Biologic Products) |
|
Approved |
Shandong Taibang Biological Products Co Ltd |
|
Mainland China |
Hemophilia B |
Shandong Taibang Biological Products Co Ltd |
2020-07-08 |
Hemophilia B |
Details
|
Factor IX (Sichuan Yuanda Shuyang Pharmaceutical) |
|
Approved |
Yuanda Shuyang Life Sciences (Chengdu) Co Ltd |
|
Mainland China |
Hemophilia B |
Yuanda Shuyang Life Sciences (Chengdu) Co Ltd |
2023-02-14 |
Hemophilia B; Hemorrhage |
Details
|
Prothrombin complex concentrat (Taibang Biological Products) |
|
Approved |
Shandong Taibang Biological Products Co Ltd |
|
Mainland China |
Hemorrhage |
Shandong Taibang Biological Products Co Ltd |
2014-09-30 |
Antithrombin III Deficiency; Hemorrhage |
Details
|
Human prothrombin complex (Hualan Biological Engineering) |
|
Approved |
Hualan Genetic Engineering Co Ltd |
|
Mainland China |
Factor X Deficiency; Blood Coagulation Disorders |
Hualan Biological Engineering Inc |
1999-01-01 |
Blood Coagulation Disorders; Hemophilia B; Factor X Deficiency |
Details
|
Enoxaparin sodium biosimilar (Sahar International Trading) |
|
Approved |
Sahar International Trading |
|
|
Angina, Unstable; ST Elevation Myocardial Infarction; Venous Thromboembolism; Blood Coagulation Disorders |
Sahar International Trading |
2013-07-01 |
Blood Coagulation Disorders; Angina, Unstable; ST Elevation Myocardial Infarction; Venous Thromboembolism |
Details
|
Human prothrombin complex concentrate (Shanxi Kangbao Biological Products) |
|
Approved |
Shanxi Kangbao Biological Product Co Ltd |
|
Mainland China |
Hemorrhage |
Shanxi Kangbao Biological Product Co Ltd |
2019-09-17 |
Hemophilia B; Hemorrhage |
Details
|
Beroctocog alfa |
GC-1101; GC-1101C |
Approved |
GC Biopharma Corp |
GreenGene F |
South Korea |
Hemophilia A |
GC Biopharma Corp |
2009-12-01 |
Hemophilia A |
Details
|
Damoctocog alfa pegol |
BAY-949027 |
Approved |
Bayer AG |
Jivi |
United States |
Hemophilia A |
Bayer Healthcare |
2018-08-29 |
Hemophilia A; Hemorrhage |
Details
|